Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension

Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. In this study, we validate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2014-06, Vol.9 (6), p.e98407-e98407
Hauptverfasser: Feres, Marcia C, Cintra, Fatima D, Rizzi, Camila F, Mello-Fujita, Luciane, Lino de Souza, Altay A, Tufik, Sergio, Poyares, Dalva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e98407
container_issue 6
container_start_page e98407
container_title PloS one
container_volume 9
creator Feres, Marcia C
Cintra, Fatima D
Rizzi, Camila F
Mello-Fujita, Luciane
Lino de Souza, Altay A
Tufik, Sergio
Poyares, Dalva
description Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. In this study, we validated a test for platelet catecholamine and compared the catecholamine levels (adrenaline and noradrenaline) in urine, plasma and platelets in patients with OSA and HYP compared with controls. In the validation, 30 healthy, nonsmoking volunteers who were not currently undergoing treatment or medication were selected as the control group. One hundred fifty-four individuals (114 OSA, 40 non-OSA) were consecutively selected from the outpatient clinic of the Sleep Institute and underwent clinical, polysomnographic and laboratory evaluation, including the urinary, plasma and platelet levels of adrenaline (AD) and noradrenaline (NA). Patients were then allocated to groups according to the presence of OSA and/or hypertension. A logistic regression model, controlled for age and BMI, showed that urinary AD and urinary NA were risk factors in the OSA+HYP group and the HYP group; however, the model showed higher levels of platelet NA for OSA without HYP. After 1 year of CPAP (continuous upper airway pressure) treatment, patients (n = 9) presented lower levels of urinary NA (p = 0.04) and platelet NA (p = 0.05). Urinary NA and AD levels were significantly associated with the condition of hypertension with and without OSA, whereas platelet NA with OSA without comorbidity. These findings suggest that platelet catecholamine levels might reflect nocturnal sympathetic activation in OSA patients without hypertension.
doi_str_mv 10.1371/journal.pone.0098407
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1534316559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A418634231</galeid><doaj_id>oai_doaj_org_article_fdb2c9a27ba440d4be548e9c33a45d05</doaj_id><sourcerecordid>A418634231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-e527e5d11cc5f1e31e69e940deb13917ae1b77efff9cf5a50f4d2e533dc729963</originalsourceid><addsrcrecordid>eNqNk11rFDEUhgdRbF39B6IBQfRi12SSzGxuhFKqFgoFv25DJjnZSckm00mm2l_hXzbb3Zau9ELmIl_PeU_OOzlV9ZLgBaEt-XARpzEovxhigAXGYslw-6g6JILW86bG9PG9-UH1LKULjDldNs3T6qBmghCypIfVn5Mr5SeVXQxIBYPKypntMlqk0BpyHw2ycUQGMoxrF1xYocGrDB4y0mXUffSqHAByAQ0lGEJO6JfLPYpdyuOks7sClDzAgNQQQN2kUmPRc8qj_nqAMg-pZH1ePbHKJ3ixG2fVj08n34-_zM_OP58eH53NdSPqPAdet8ANIVpzS4ASaAQIhg10hArSKiBd24K1VmjLFceWmRo4pUa3tRANnVWvt7qDj0nuvEyScMooaTgXhTjdEiaqCzmMbq3GaxmVkzcbcVzJUoHTHqQ1Xa2FqttOsXIH1gFnSxCaUsW4Ka7Pqo-7bFO3BqOLQaPye6L7J8H1chWvJMNM8CUuAu92AmO8nCBluXZJg_cqQJy2924F5g0r6Jt_0Ier21ErVQpwwcaSV29E5REjy4aympJCLR6gymdg7XR5eNaV_b2A93sBhcnwO6_UlJI8_fb1_9nzn_vs23tsD8rnPkU_bR5q2gfZFtRjTGkEe2cywXLTN7duyE3fyF3flLBX93_QXdBto9C_K98Whg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534316559</pqid></control><display><type>article</type><title>Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Feres, Marcia C ; Cintra, Fatima D ; Rizzi, Camila F ; Mello-Fujita, Luciane ; Lino de Souza, Altay A ; Tufik, Sergio ; Poyares, Dalva</creator><contributor>Najbauer, Joseph</contributor><creatorcontrib>Feres, Marcia C ; Cintra, Fatima D ; Rizzi, Camila F ; Mello-Fujita, Luciane ; Lino de Souza, Altay A ; Tufik, Sergio ; Poyares, Dalva ; Najbauer, Joseph</creatorcontrib><description>Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. In this study, we validated a test for platelet catecholamine and compared the catecholamine levels (adrenaline and noradrenaline) in urine, plasma and platelets in patients with OSA and HYP compared with controls. In the validation, 30 healthy, nonsmoking volunteers who were not currently undergoing treatment or medication were selected as the control group. One hundred fifty-four individuals (114 OSA, 40 non-OSA) were consecutively selected from the outpatient clinic of the Sleep Institute and underwent clinical, polysomnographic and laboratory evaluation, including the urinary, plasma and platelet levels of adrenaline (AD) and noradrenaline (NA). Patients were then allocated to groups according to the presence of OSA and/or hypertension. A logistic regression model, controlled for age and BMI, showed that urinary AD and urinary NA were risk factors in the OSA+HYP group and the HYP group; however, the model showed higher levels of platelet NA for OSA without HYP. After 1 year of CPAP (continuous upper airway pressure) treatment, patients (n = 9) presented lower levels of urinary NA (p = 0.04) and platelet NA (p = 0.05). Urinary NA and AD levels were significantly associated with the condition of hypertension with and without OSA, whereas platelet NA with OSA without comorbidity. These findings suggest that platelet catecholamine levels might reflect nocturnal sympathetic activation in OSA patients without hypertension.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0098407</identifier><identifier>PMID: 24911183</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Apnea ; Biology and Life Sciences ; Blood Chemical Analysis - methods ; Blood platelets ; Blood Platelets - chemistry ; Body mass ; Care and treatment ; Catecholamine ; Catecholamines ; Catecholamines - blood ; Comparative analysis ; Continuous Positive Airway Pressure ; Control methods ; Disease ; Drugs ; Epinephrine ; Evaluation ; Experiments ; Female ; Humans ; Hypertension ; Hypertension - complications ; Logistic Models ; Male ; Medicine and Health Sciences ; Methods ; Middle Aged ; Noradrenaline ; Norepinephrine ; Patients ; Physical Sciences ; Platelets ; Psychobiology ; Regression models ; Respiratory tract ; Risk analysis ; Risk factors ; Sleep ; Sleep apnea ; Sleep Apnea, Obstructive - blood ; Sleep Apnea, Obstructive - complications ; Sleep Apnea, Obstructive - therapy ; Sleep disorders ; Studies ; Sympathetic nervous system ; Urine ; Young Adult</subject><ispartof>PloS one, 2014-06, Vol.9 (6), p.e98407-e98407</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 Feres et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 Feres et al 2014 Feres et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-e527e5d11cc5f1e31e69e940deb13917ae1b77efff9cf5a50f4d2e533dc729963</citedby><cites>FETCH-LOGICAL-c692t-e527e5d11cc5f1e31e69e940deb13917ae1b77efff9cf5a50f4d2e533dc729963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049580/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049580/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,2914,23846,27903,27904,53769,53771,79346,79347</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24911183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Najbauer, Joseph</contributor><creatorcontrib>Feres, Marcia C</creatorcontrib><creatorcontrib>Cintra, Fatima D</creatorcontrib><creatorcontrib>Rizzi, Camila F</creatorcontrib><creatorcontrib>Mello-Fujita, Luciane</creatorcontrib><creatorcontrib>Lino de Souza, Altay A</creatorcontrib><creatorcontrib>Tufik, Sergio</creatorcontrib><creatorcontrib>Poyares, Dalva</creatorcontrib><title>Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. In this study, we validated a test for platelet catecholamine and compared the catecholamine levels (adrenaline and noradrenaline) in urine, plasma and platelets in patients with OSA and HYP compared with controls. In the validation, 30 healthy, nonsmoking volunteers who were not currently undergoing treatment or medication were selected as the control group. One hundred fifty-four individuals (114 OSA, 40 non-OSA) were consecutively selected from the outpatient clinic of the Sleep Institute and underwent clinical, polysomnographic and laboratory evaluation, including the urinary, plasma and platelet levels of adrenaline (AD) and noradrenaline (NA). Patients were then allocated to groups according to the presence of OSA and/or hypertension. A logistic regression model, controlled for age and BMI, showed that urinary AD and urinary NA were risk factors in the OSA+HYP group and the HYP group; however, the model showed higher levels of platelet NA for OSA without HYP. After 1 year of CPAP (continuous upper airway pressure) treatment, patients (n = 9) presented lower levels of urinary NA (p = 0.04) and platelet NA (p = 0.05). Urinary NA and AD levels were significantly associated with the condition of hypertension with and without OSA, whereas platelet NA with OSA without comorbidity. These findings suggest that platelet catecholamine levels might reflect nocturnal sympathetic activation in OSA patients without hypertension.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Apnea</subject><subject>Biology and Life Sciences</subject><subject>Blood Chemical Analysis - methods</subject><subject>Blood platelets</subject><subject>Blood Platelets - chemistry</subject><subject>Body mass</subject><subject>Care and treatment</subject><subject>Catecholamine</subject><subject>Catecholamines</subject><subject>Catecholamines - blood</subject><subject>Comparative analysis</subject><subject>Continuous Positive Airway Pressure</subject><subject>Control methods</subject><subject>Disease</subject><subject>Drugs</subject><subject>Epinephrine</subject><subject>Evaluation</subject><subject>Experiments</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Noradrenaline</subject><subject>Norepinephrine</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Platelets</subject><subject>Psychobiology</subject><subject>Regression models</subject><subject>Respiratory tract</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Sleep</subject><subject>Sleep apnea</subject><subject>Sleep Apnea, Obstructive - blood</subject><subject>Sleep Apnea, Obstructive - complications</subject><subject>Sleep Apnea, Obstructive - therapy</subject><subject>Sleep disorders</subject><subject>Studies</subject><subject>Sympathetic nervous system</subject><subject>Urine</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11rFDEUhgdRbF39B6IBQfRi12SSzGxuhFKqFgoFv25DJjnZSckm00mm2l_hXzbb3Zau9ELmIl_PeU_OOzlV9ZLgBaEt-XARpzEovxhigAXGYslw-6g6JILW86bG9PG9-UH1LKULjDldNs3T6qBmghCypIfVn5Mr5SeVXQxIBYPKypntMlqk0BpyHw2ycUQGMoxrF1xYocGrDB4y0mXUffSqHAByAQ0lGEJO6JfLPYpdyuOks7sClDzAgNQQQN2kUmPRc8qj_nqAMg-pZH1ePbHKJ3ixG2fVj08n34-_zM_OP58eH53NdSPqPAdet8ANIVpzS4ASaAQIhg10hArSKiBd24K1VmjLFceWmRo4pUa3tRANnVWvt7qDj0nuvEyScMooaTgXhTjdEiaqCzmMbq3GaxmVkzcbcVzJUoHTHqQ1Xa2FqttOsXIH1gFnSxCaUsW4Ka7Pqo-7bFO3BqOLQaPye6L7J8H1chWvJMNM8CUuAu92AmO8nCBluXZJg_cqQJy2924F5g0r6Jt_0Ier21ErVQpwwcaSV29E5REjy4aympJCLR6gymdg7XR5eNaV_b2A93sBhcnwO6_UlJI8_fb1_9nzn_vs23tsD8rnPkU_bR5q2gfZFtRjTGkEe2cywXLTN7duyE3fyF3flLBX93_QXdBto9C_K98Whg</recordid><startdate>20140609</startdate><enddate>20140609</enddate><creator>Feres, Marcia C</creator><creator>Cintra, Fatima D</creator><creator>Rizzi, Camila F</creator><creator>Mello-Fujita, Luciane</creator><creator>Lino de Souza, Altay A</creator><creator>Tufik, Sergio</creator><creator>Poyares, Dalva</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140609</creationdate><title>Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension</title><author>Feres, Marcia C ; Cintra, Fatima D ; Rizzi, Camila F ; Mello-Fujita, Luciane ; Lino de Souza, Altay A ; Tufik, Sergio ; Poyares, Dalva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-e527e5d11cc5f1e31e69e940deb13917ae1b77efff9cf5a50f4d2e533dc729963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Apnea</topic><topic>Biology and Life Sciences</topic><topic>Blood Chemical Analysis - methods</topic><topic>Blood platelets</topic><topic>Blood Platelets - chemistry</topic><topic>Body mass</topic><topic>Care and treatment</topic><topic>Catecholamine</topic><topic>Catecholamines</topic><topic>Catecholamines - blood</topic><topic>Comparative analysis</topic><topic>Continuous Positive Airway Pressure</topic><topic>Control methods</topic><topic>Disease</topic><topic>Drugs</topic><topic>Epinephrine</topic><topic>Evaluation</topic><topic>Experiments</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Noradrenaline</topic><topic>Norepinephrine</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Platelets</topic><topic>Psychobiology</topic><topic>Regression models</topic><topic>Respiratory tract</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Sleep</topic><topic>Sleep apnea</topic><topic>Sleep Apnea, Obstructive - blood</topic><topic>Sleep Apnea, Obstructive - complications</topic><topic>Sleep Apnea, Obstructive - therapy</topic><topic>Sleep disorders</topic><topic>Studies</topic><topic>Sympathetic nervous system</topic><topic>Urine</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feres, Marcia C</creatorcontrib><creatorcontrib>Cintra, Fatima D</creatorcontrib><creatorcontrib>Rizzi, Camila F</creatorcontrib><creatorcontrib>Mello-Fujita, Luciane</creatorcontrib><creatorcontrib>Lino de Souza, Altay A</creatorcontrib><creatorcontrib>Tufik, Sergio</creatorcontrib><creatorcontrib>Poyares, Dalva</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feres, Marcia C</au><au>Cintra, Fatima D</au><au>Rizzi, Camila F</au><au>Mello-Fujita, Luciane</au><au>Lino de Souza, Altay A</au><au>Tufik, Sergio</au><au>Poyares, Dalva</au><au>Najbauer, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-06-09</date><risdate>2014</risdate><volume>9</volume><issue>6</issue><spage>e98407</spage><epage>e98407</epage><pages>e98407-e98407</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. In this study, we validated a test for platelet catecholamine and compared the catecholamine levels (adrenaline and noradrenaline) in urine, plasma and platelets in patients with OSA and HYP compared with controls. In the validation, 30 healthy, nonsmoking volunteers who were not currently undergoing treatment or medication were selected as the control group. One hundred fifty-four individuals (114 OSA, 40 non-OSA) were consecutively selected from the outpatient clinic of the Sleep Institute and underwent clinical, polysomnographic and laboratory evaluation, including the urinary, plasma and platelet levels of adrenaline (AD) and noradrenaline (NA). Patients were then allocated to groups according to the presence of OSA and/or hypertension. A logistic regression model, controlled for age and BMI, showed that urinary AD and urinary NA were risk factors in the OSA+HYP group and the HYP group; however, the model showed higher levels of platelet NA for OSA without HYP. After 1 year of CPAP (continuous upper airway pressure) treatment, patients (n = 9) presented lower levels of urinary NA (p = 0.04) and platelet NA (p = 0.05). Urinary NA and AD levels were significantly associated with the condition of hypertension with and without OSA, whereas platelet NA with OSA without comorbidity. These findings suggest that platelet catecholamine levels might reflect nocturnal sympathetic activation in OSA patients without hypertension.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24911183</pmid><doi>10.1371/journal.pone.0098407</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2014-06, Vol.9 (6), p.e98407-e98407
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1534316559
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Adolescent
Adult
Apnea
Biology and Life Sciences
Blood Chemical Analysis - methods
Blood platelets
Blood Platelets - chemistry
Body mass
Care and treatment
Catecholamine
Catecholamines
Catecholamines - blood
Comparative analysis
Continuous Positive Airway Pressure
Control methods
Disease
Drugs
Epinephrine
Evaluation
Experiments
Female
Humans
Hypertension
Hypertension - complications
Logistic Models
Male
Medicine and Health Sciences
Methods
Middle Aged
Noradrenaline
Norepinephrine
Patients
Physical Sciences
Platelets
Psychobiology
Regression models
Respiratory tract
Risk analysis
Risk factors
Sleep
Sleep apnea
Sleep Apnea, Obstructive - blood
Sleep Apnea, Obstructive - complications
Sleep Apnea, Obstructive - therapy
Sleep disorders
Studies
Sympathetic nervous system
Urine
Young Adult
title Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T09%3A58%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20and%20validation%20of%20a%20method%20for%20determining%20platelet%20catecholamine%20in%20patients%20with%20obstructive%20sleep%20apnea%20and%20arterial%20hypertension&rft.jtitle=PloS%20one&rft.au=Feres,%20Marcia%20C&rft.date=2014-06-09&rft.volume=9&rft.issue=6&rft.spage=e98407&rft.epage=e98407&rft.pages=e98407-e98407&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0098407&rft_dat=%3Cgale_plos_%3EA418634231%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1534316559&rft_id=info:pmid/24911183&rft_galeid=A418634231&rft_doaj_id=oai_doaj_org_article_fdb2c9a27ba440d4be548e9c33a45d05&rfr_iscdi=true